Dr. Marcus Wilson is President of HealthCore, Anthem’s wholly-owned outcomes research subsidiary. HealthCore utilizes Anthem’s rich data and extensive provider network to meet the evidence development needs of a broad array of healthcare stakeholders including Anthem, State and Federal agencies and the Life Sciences industry. He has been extensively involved in efforts to utilize electronic healthcare data environments to accelerate healthcare evidence development and to facilitate clinical decision support for more than 20 years.
Marcus is active on a number of boards and serves as chair of several national committees. Prior to co-founding HealthCore in 1996, Dr. Wilson spent seven years within an integrated delivery system owned by BCBS of Delaware where he oversaw the physician and patient clinical decision support, pharmacy policy and clinical trials programs.
Under certain circumstances, opening up the design options in the pre-approval phases of drug development to include Pragmatic Clinical Trials (PCT’s) has the potential to greatly enrich and complement the findings from traditional RCT’s and, earlier in the drug approval process, broaden the generation of evidence more relevant to treated patients.
Large-scale alliance collaborations present a massive opportunity for stakeholders to work together to inform the decisions that have the power to make healthcare safer, lower cost, and higher quality.